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Abstract
Cell-to-cell transmission of toxic forms of α-Synuclein (αS) is thought to underlie disease
progression in Parkinson disease. αS in humans is constitutively N-terminally acetylated
(αSacetyl), although the impact of this modification is relatively unexplored. Here, we report
that αSacetyl is more effective at inducing intracellular aggregation in primary neurons than
unmodified αS (αSun). We identify complex N-linked glycans as binding partners for αSacetyl
and demonstrate that cellular internalization of αSacetyl is reduced significantly upon cleav-
age of extracellular N-linked glycans, but not other carbohydrates. We verify binding of
αSacetyl to N-linked glycans in vitro, using both isolated glycans and cell-derived proteolipo-
somes. Finally, we identify neurexin 1β, a neuronal glycoprotein, as capable of driving gly-
can-dependent uptake of αSacetyl. Importantly, our results are specific to αSacetyl because
αSun does not demonstrate sensitivity for N-linked glycans in any of our assays. Our study
identifies extracellular N-linked glycans—and the glycoprotein neurexin 1β specifically—as
key modulators of neuronal uptake of αSacetyl, drawing attention to the potential therapeutic
value of αSacetyl-glycan interactions.
Introduction
The pathologies of Parkinson disease and related synucleinopathies are characterized by the accu-
mulation of aggregates of the neuronal protein α-Synuclein (αS) [1]. The prevailing hypothesis is
that toxicity is mediated by prefibrillar oligomers of αS [2]. Emerging evidence suggests that cell-
to-cell transmission of toxic αS species may be the basis of disease propagation [3].
αS is a small, soluble protein that is intrinsically disordered in the cytoplasm [4]. It associ-
ates peripherally to anionic lipid bilayers through its N-terminal domain, which becomes α-
helical upon binding [5]. The localization of αS to nerve terminals [6,7] and to cellular lipid
raft domains [8] suggests that there are components or properties of cellular membranes that
are important for αS binding and function that may not be fully reproduced by simple lipid
mixtures. Indeed, specific components of the extracellular membrane, including proteins [9]
and proteoglycans [10], have been identified as having roles in the uptake of pathogenic αS
species.
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αS is subject to various post-translational modifications, including phosphorylation, ubi-
quitination, glycation, acetylation, and arginylation, some of which are correlated with pathol-
ogy [11–13]. Mass spectrometry analysis indicates that the majority of these modifications are
found on only a very small fraction of αS [14]. N-terminal acetylation, however, is unique in
that it appears to be present on the majority of αS in vivo [11,15,16], in both healthy persons
and patients with Parkinson disease [14,15]. Acetylation of the amino terminus occurs co-
translationally [17], and, for many proteins, it is required for recognition of cellular binding
partners [18]. Work from our group [19] and others have demonstrated that N-terminal acety-
lation alters the fundamental biophysical properties of αS; it moderately affects its binding to
synthetic lipid bilayers [5,20] and rates of aggregation [20]. How this modification impacts
interactions with other cellular binding partners—and in particular the plasma membrane
proteins that have been identified as receptors involved in cellular uptake and aggregation—
has not been explored. Here, we investigate the role of N-terminal acetylation of αS on cellular
binding and internalization. Using cell biological and biophysical approaches, we demonstrate
that N-terminal acetylation of αS confers interactions with extracellular N-linked glycans that
impact cellular uptake, identify neurexin 1β as a receptor for glycan-dependent uptake of αS,
and provide insight into the mechanism of cellular recognition relevant to uptake.
Results
N-terminal acetylation of αS enhances formation of intracellular
aggregates in neurons
Recently, observations that exogenously added aggregates of αS are capable of seeding aggregation
of endogenous αS have prompted an interest in understanding the molecular players involved.
However, investigations of this phenomenon have relied on aggregates composed of unmodified
αS (αSun). To determine whether N-terminal acetylation of αS (αSacetyl) alters this seeding behav-
ior, primary hippocampal neurons were incubated with preformed fibrils (PFFs) of αSacetyl or
αSun [21] (S1 Fig). Both αSacetyl and αSun PFFs resulted in the formation of abundant intracellular
aggregates (Fig 1A), demonstrating that the internalized material retains its fibrillar character, as
previously characterized [2]. However, the kinetics of aggregate formation differ significantly. For
αSun PFFs, the time course was in good agreement with previously published studies [21]; aggre-
gates were observed in axons by day 7 and had spread to somatodendritic compartments by day
10. For αSacetyl PFFs, aggregates in axons were already prevalent by day 3, and spreading to soma-
todentric compartments was readily apparent by day 7. Measurements beyond 7 days were not
possible for neurons treated with αSacetyl PFFs due to significant cell death.
To compare the effectiveness of αSacetyl and αSun PFFs in nucleating intracellular aggregate
formation and growth, we quantified the total number of aggregates per neuron, reflecting the
seeding capacity of the added αS PFFs (i.e., their ability to induce the initial formation of intra-
cellular αS aggregates), as well as total aggregate area per neuron, reflecting the overall ability
of the added αS PFFs to accelerate further aggregate growth. This quantification revealed that
the overall rate of aggregate formation is >2-fold faster for neurons treated with αSacetyl PFFs
compared with αSun PFFs (Fig 1B). This result demonstrates that αSacetyl PFFs are markedly
more potent seeds for pathological propagation of αS aggregation in neurons.
αSacetyl is more rapidly internalized by SH-SY5Y cells than αSun
This observation sparked our interest in determining the origin in differences in aggregate
propagation in neurons. To do so, human neuroblastoma (SH-SY5Y) cells were chosen
because they retain many of the pathways dysregulated in Parkinson disease and thus are
Glycan-dependent cellular uptake of α-Synuclein
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widely used as a cellular model for disease. Moreover, SH-SY5Y cells spontaneously internalize
αS without requiring the use of a transfection agent [22]. SH-SY5Y cells were incubated with
monomer or PFF αS fluorescently labeled with Alexa Fluor 488 (αS-AL488). After 12 hours
of incubation, monomer and PFF αSacetyl and αSun appeared as puncta, colocalized with an
endosomal marker (Fig 2A and 2B, S2A and S2B Fig). In order to make a more quantitative
comparison of both kinetics and quantity of uptake between αSacetyl and αSun, cellular inter-
nalization was measured as a function of time. Three orthogonal methods were used to quan-
tify uptake: (1) loss of monomer αS from the cell media was measured using fluorescence
correlation spectroscopy (FCS) [23], (2) the amounts of internalized monomer and PFF αS
were quantified by confocal imaging, or (3) both extracellular and internalized monomer and
PFF αS were quantified by polyacrylamide gel electrophoresis (S3 Fig). Results of all three of
these approaches are consistent and reveal that both monomer and PFF αSacetyl are internal-
ized more rapidly (Fig 2C) and to a greater extent (Fig 2D, S3 Fig) than αSun. Uptake was
inhibited at 4˚C, indicating that active endocytotic pathways are required (S4A Fig). Control
measurements made using non-neuronal lineage human embryonic kidney 293T (HEK) cells
Fig 1. αSacetyl PFFs are more effective at inducing pathological aggregates in primary neurons. (A) Representative
images of aggregates of endogenous αS in cultured mouse hippocampal neurons following incubation with αSacetyl or
αSun PFFs. Images shown at day 7 in the absence of PFFs (upper row) and after 3 and 7 days following treatment with
PFFs. Red: αS-pS129 antibody; blue: βIII-tubulin antibody. (B) Quantification of αS aggregates as seen in images in
(A). Aggregates in neurons treated with αSacetyl PFFs are larger and more numerous. n = 80 neurons, 3 independent
experiments, ��P< 0.001 and ���P< 0.0001 by Student t test compared to αSun PFF-treated neurons. The data are
presented as mean ± SD, n = 3. Scale bars = 20 μm. The underlying data for this figure can be found in S1 Data. αS, α-
Synuclein; αS-pS129, αS phosphorylated at serine 129; αSacetyl, N-terminally acetylated αS; αSun, unmodified αS; PFF,
preformed fibril.
https://doi.org/10.1371/journal.pbio.3000318.g001
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Fig 2. Complex N-linked glycans selectively enhance uptake of αSacetyl by SH-SY5Y cells. (A) Representative images of SH-SY5Y cells following
12-hour incubation with monomer or PFF αSacetyl-AL488, −/+ PNGase F treatment. (B) As in (A) but for monomer or PFF αSun -AL488. (C) Upper:
kinetics of internalization by SH-SY5Y cells of monomer αS as quantified by loss from extracellular medium by FCS, −/+ PNGase F treatment.
Lower: kinetics of internalization by SH-SY5Y cells of PFF αS as quantified by puncta analysis of confocal images, −/+ PNGase F treatment. (D)
Quantification of internalization of αS PFFs by SH-SY5Y cells, −/+ Heparinase I/III treatment. Images collected following 12-hour incubation with
protein and quantified by puncta analysis. (E) Quantification of internalization of αS monomer and PFF by SH-SY5Y cells, −/+ PNGase F treatment.
Glycan-dependent cellular uptake of α-Synuclein
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found no spontaneous internalization of either αSacetyl or αSun (S4B Fig), consistent with prior
studies of αS uptake by HEK cells that utilized transfection agents [24–26]. Both SH-SY5Y and
HEK cells showed rapid uptake of transferrin, indicating that lack of αS internalization is not
due to inherent differences in rates of clathrin-dependent endocytosis between the cell lines
(S4C Fig).
Cleavage of extracellular N-linked glycans inhibits uptake of αSacetyl by
SH-SY5Y cells
Cell-surface heparan sulfate proteoglycans have been observed to promote uptake of a number
of fibrillar amyloid proteins, including αSun PFFs [27]. To investigate the relevance of proteo-
glycans to αSacetyl uptake, SH-SY5Y cells were treated with Heparinase I/III, an enzyme that
cleaves these carbohydrates, for 6 hours. After exchange of media to remove the enzyme,
αS-AL488 was added and incubated an additional 12 hours. This incubation period was cho-
sen because it allows for reproducible quantification of puncta, and there is no evidence of
protein or fluorophore degradation that may occur at longer time points (S2B Fig). In agree-
ment with previous reports, we found that treatment of SH-SY5Y cells with Heparinase
reduced the uptake of αSun PFFs (Fig 2D, S5A Fig). Interestingly, however, Heparinase pre-
treatment did not alter uptake of αSacetyl PFFs nor that of αSacetyl monomer (Fig 2D, S5A and
S5B Fig).
These results prompted us to consider other endoglycosidases, as the majority of cell-sur-
face proteins are modified by glycosylation [28], including a number of proteins that have
been identified as receptors for αSun PFFs [9,29,30]. Complex N-linked glycans were selectively
removed from SH-SY5Y cells using peptide-N-glycosidase F (PNGase F). Following incuba-
tion with αSacetyl, a decrease in the number of intracellular puncta in the PNGase F–treated
cells relative to untreated cells was observed, both for monomer and PFF αSacetyl, reflecting a
significant decrease in uptake by deglycosylated cells (Fig 2A, 2C and 2E, S3 Fig). Removal of
N-linked glycans was confirmed using concanavalin A (con A), a lectin that binds α-D-man-
nose and α-D-glucose moieties found on N-linked glycans (S5C Fig). Control measurements
showed that PNGase F treatment did not impact clathrin-dependent endocytosis (S5D Fig).
Under our measurement conditions (200 nM protein and 12-hour incubation), neither
untreated nor PNGase F–treated cells showed evidence of increased toxicity upon incubation
with monomer or PFF αSacetyl or αSun (S5E Fig). Moreover, and strikingly, internalization of
monomer and PFF αSun did not demonstrate sensitivity to PNGase F treatment (Fig 2B, 2C
and 2E). Lastly, we tested endoglycosidase H (Endo H), which cleaves high mannose N-linked
carbohydrates, and found that this enzyme had only a minor impact on uptake of αSacetyl by
SH-SY5Y cells (S5B Fig).
Our observations in SH-SY5Y cells were corroborated in cultured primary hippocampal
neurons. Monomer and PFF αSacetyl and αSun were readily internalized by primary hippocam-
pal neurons (Fig 3A and 3B). Removal of extracellular N-linked glycans by PNGase F resulted
in a 10-fold decrease in the amount of internalized αSacetyl (Fig 3A), while no effect was
observed for αSun (Fig 3B). Similar to our observation in SH-SY5Y cells, PNGase F treatment
of neurons caused no defects in clathrin-dependent endocytosis (S5D Fig).
Images collected following 12-hour incubation with protein and quantified by puncta analysis. All protein uptake measurements with 200 nM
monomer or 200 nM PFFs (monomer units, 20:1 αS:αS-AL488); n = 100 cells, 3 independent experiments, ���P< 0.0001 by Student t test). Scale
bars = 20 μm. The underlying data for this figure can be found in S1 Data. αS, α-Synuclein; αSacetyl, N-terminally acetylated αS; αSun, unmodified αS;
AL488, Alexa Fluor 488; FCS, fluorescence correlation spectroscopy; PFF, preformed fibril; PNGase F, peptide-N-glycosidase F; SH-SY5Y, human
neuroblastoma.
https://doi.org/10.1371/journal.pbio.3000318.g002
Glycan-dependent cellular uptake of α-Synuclein
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000318 June 18, 2019 5 / 29
Removal of complex N-linked glycans alters αS binding to SH-SY5Y
GPMVs
Our results thus far support specific interactions between αSacetyl and complex, N-linked gly-
cans found on neurons and SH-SY5Y, but not HEK, cells that drive internalization of both
monomer and PFF αSacetyl. To investigate the molecular details of the interactions of αS with
cell-surface glycans, we used cell membrane–derived giant plasma membrane vesicles
(GPMVs) that have a lipid and protein composition that closely resembles the cell plasma
membrane [31]. Thus, they serve as an excellent model of the cell membrane while lacking the
active processes of cells, such as uptake, allowing for binding interactions to be observed.
GPMVs were harvested from SH-SY5Y cells and incubated with monomer and PFF αSacetyl-
AL488. Both monomer and PFF αSacetyl-AL488 formed large, bright assemblies on the exterior
of the SH-SY5Y GMPVs and caused their clustering, with larger assemblies and more clusters
observed with increasing protein concentrations (Fig 4A, S6A and S6B Fig). Monomer and
PFF αSun-AL488, on the other hand, bound more uniformly and apparently more weakly than
αSacetyl (Fig 4B, S6C Fig). The images present a striking contrast, suggesting differences in
Fig 3. Complex N-linked glycans selectively enhance uptake of αSacetyl by primary hippocampal neurons. (A) Representative
images of mouse hippocampal neurons cells following 12-hour incubation with monomer or PFF αSacetyl-AL488, −/+ PNGase F
treatment. Uptake quantified by total cellular fluorescence. (B) As in (A) but for monomer and PFF αSun-AL488. All internalization
measurements with 200 nM monomer or 200 nM PFF (monomer units, 20:1 αS:αS-AL488); n = 100 cells, 3 independent
experiments, �P< 0.01 and ���P< 0.0001 by Student t test). Scale bars = 20 μm. The underlying data for this figure can be found in
S1 Data. αS, α-Synuclein; αSacetyl, N-terminally acetylated αS; αSun, unmodified αS; AL488, Alexa Fluor 488; PFF, preformed fibril;
PNGase F, peptide-N-glycosidase F.
https://doi.org/10.1371/journal.pbio.3000318.g003
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binding affinity for αSacetyl and αSun. Binding of monomer αS to GPMVs was quantified by
FCS (Fig 4C). In these experiments, monomer αS-AL488 was added to GPMVs in a sample
chamber, and the amount of αS-AL488 that remained in solution after incubation was deter-
mined. After 60 minutes of incubation, 47% ± 4% of αSun and 80% ± 6% of αSacetyl were
bound to the GPMVs (Fig 4C). Direct quantification of GPMV fluorescence resulting from
αS-AL488 binding was consistent with the FCS results (S6D Fig).
Carbohydrates were selectively removed from the extracellular surface of the SH-SY5Y
GPMVs by incubation with the same endoglycosidases used in the cell uptake measurements.
Treatment with PNGase F resulted in a loss of inhomogenous binding and the bright αSacetyl
Fig 4. Removal of N-linked glycans disrupts binding of αSacetyl to SH-SY5Y proteoliposomes. (A) Images of
SH-SY5Y GPMVs incubated with 100 nM αSacetyl-AL488 and unlabeled αSacetyl (concentrations indicated). (B) Upper: as
in (A) but with 100 nM αSun-AL488 and 80 μM unlabeled αSun. Lower: as in upper panel but with treatment with
PNGase F. (C) Binding of 80 nM αSacetyl-AL488 or αSun-AL488 to GPMVs quantified by FCS as loss of protein (N,
number of molecules) from solution. The number of molecules in control wells lacking GPMVs is indicated by the red-
dashed line. (D) Representative images of SH-SY5Y GPMVs incubated with 100 nM αSacetyl-AL488 and 80 μM unlabeled
αSacetyl after treatment of GPMVs with the indicated endoglycosidase. (E) Binding of αSacetyl-AL488 to Heparinase- and
Endo H-treated SH-SY5Y GPMVs measured by FCS, as in panel C. Binding +/− PNGase F from panel C shown for
comparison. (F) GPMVs incubated with 50 nM conA-AL488 in the absence and presence of 100 nM αSacetyl-AL594 and
80 μM of unlabeled αSacetyl. The data are presented as mean ± SD, n = 3. Scale bars = 10 μm. The underlying data for this
figure can be found in S1 Data. αS, α-Synuclein; αSacetyl, N-terminally acetylated αS; αSun, unmodified αS; AL488, Alexa
Fluor 488; Endo H, endoglycosidase H; FCS, fluorescence correlation spectroscopy; GPMV, giant plasma membrane
vesicle; PNGase F, peptide-N-glycosidase F; SH-SY5Y, human neuroblastoma; conA-AL488, AL488-labeled conA.
https://doi.org/10.1371/journal.pbio.3000318.g004
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assemblies (Fig 4D, S6E Fig), as well as significantly decreased the amount of bound αSacetyl
(Fig 4E). In contrast, binding of αSun to SH-SY5Y GPMVs was unaltered by PNGase F treat-
ment (Fig 4B). By comparison, bright αSacetyl assemblies were still observed after treatment
with Heparinase or Endo H (Fig 4D and 4E, S6F Fig), consistent with our cellular uptake mea-
surements. Also consistent with our cellular uptake measurements is that very weak binding
was observed for αSacetyl to GPMVs derived from HEK cells (S6G Fig).
Uniform binding of Alexa 488-labeled conA (conA-AL488) to SH-SY5Y GPMVs demon-
strates that glycoproteins were distributed throughout the GPMV bilayer in the absence of
αSacetyl (Fig 4F, S6H Fig); treatment with PNGase F significantly reduced the amount of conA
bound (S6H Fig). The addition of αSacetyl resulted in clustering of conA-stained proteins (Fig
4F, S6I and S6J Fig). αSacetyl appeared to induce assembly through binding to and noncova-
lently crosslinking multiple membrane glycoproteins, likely observed because GPMVs lack an
intact cytoskeleton that would otherwise restrict large-scale rearrangement of plasma mem-
brane proteins.
αSacetyl binds complex N-linked glycans with a distinct structure
Because its native function is thought to involve interactions with cellular membranes, binding
of αS to synthetic lipid vesicles has been thoroughly investigated by a number of experimental
methods [32–34]. The interaction is mediated through the first approximately 95 residues of
αS, which form an α-helix upon binding to synthetic lipid vesicles [33,35]. To interrogate the
conformational features of αS bound to GPMVs, intramolecular Förster resonance energy
transfer (FRET) measurements were made. αS was labeled at residues 9 and 72, positions
encompassing much of the membrane-binding domain. Mean energy transfer efficiencies
(ETeff) of αSacetyl and αSun bound to SH-SY5Y GPMVs were 0.43 ± 0.08 and 0.21 ± 0.06,
respectively (Fig 5A and 5B). This lower ETeff measured for αSun was consistent with a single,
long α-helix that we have previously measured using single-molecule FRET for αS bound to
synthetic lipid vesicles [35]. The higher ETeff measured for αSacetyl demonstrates that it binds
in a distinct conformation. Strikingly, when complex N-linked glycans were removed from
GPMVs by treatment with PNGase F, ETeff distribution peaks of 0.19 ± 0.06 and 0.17 ± 0.03
were observed for αSacetyl and αSun, respectively (Fig 5A and 5B). Our interpretation of these
findings is that, in the absence of complex N-linked glycans, αSacetyl binds to GPMVs through
interactions with the lipid bilayer resulting in a predominantly extended conformation. In the
presence of N-linked glycans, αSacetyl binding is enhanced, and it assumes a conformation dis-
tinct from the extended, membrane-bound α-helix. The higher mean ETeff and relatively
broad distribution of αSacetyl may reflect a dynamic, disordered C-terminal half of the mem-
brane-binding domain that does not strongly associate with the GPMVs in the presence of sur-
face glycans. Binding of αSun, on the other hand, occurs primarily through its interactions
with the lipid bilayer resulting in the extended helical state even in the presence of N-linked
glycans. These results provide a basis for understanding why no differences in GPMV binding
(Fig 4C) or in cellular uptake (Figs 2C, 2E and 3B) were observed for αSun upon PNGase F
treatment.
αSacetyl binds isolated N-linked glycans from SH-SY5Y cells
To identify whether αSacetyl binding to glycans requires either the associated glycoproteins or a
lipid bilayer, binding to isolated glycans in solution was measured by FCS. SH-SY5Y cells were
treated with each of the 3 endoglycosidases used in the cell and GPMV experiments, and the
cleaved carbohydrates were retained. The carbohydrates were titrated into αSacetyl-AL488 for
FCS measurements, and the autocorrelation curves (S7A Fig) were fit to extract the diffusion
Glycan-dependent cellular uptake of α-Synuclein
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time and average number of fluorescent molecules, N (Fig 6A, S7B Fig). The diffusion time—
which reflects the hydrodynamic size of the diffusing species—of αSacetyl increased more than
25% with increasing concentrations of PNGase F–derived glycans, comparable to similar mea-
surements of conA-AL488 (Fig 6A and 6B, S7C Fig). No increase in the diffusion time of αSun
was observed in the presence of PNGase F–derived glycans (Fig 6A). Similarly, the addition of
Fig 5. Intramolecular FLIM-FRET measurements of αS bound to SH-SY5Y GPMVs. (A) FLIM-FRET
measurements of αSacetyl bound to GPMVs without (upper) and with (lower) treatment with PNGase F. Left:
representative image of a GPMV, colored by donor fluorophore lifetime shown in the scale bar. Right: histogram of
ETeff calculated from the images, with Gaussian fits shown. The pixels used to calculate the histograms are indicated by
dashed lines on the GPMV images. (B) As in (A) but with αSun. Histograms indicated are an average of 3 GPMVs per
biological replicate (n = 3). The underlying data for this figure can be found in S1 Data. αS, α-Synuclein; αSacetyl, N-
terminally acetylated αS; αSun, unmodified αS; ETeff, energy transfer efficiency; FLIM, fluorescence lifetime imaging
microscopy; FRET, Förster resonance energy transfer; GPMV, giant plasma membrane vesicle; PNGase F, peptide-N-
glycosidase F.
https://doi.org/10.1371/journal.pbio.3000318.g005
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carbohydrates obtained from Endo H or Heparinase treatment of SH-SY5Y cells or PNGase F
treatment of HEK cells resulted in minimal changes in the diffusion time of αSacetyl by FCS
(Fig 6B, S7D Fig). Nuclear magnetic resonance (NMR) measurements showed nonuniform
glycan-dependent changes in αSacetyl peak intensity in the presence of PNGase F–cleaved gly-
cans, but not simple carbohydrates (Fig 6C and 6D). These changes likely result not only from
direct and specific interactions of αSacetyl with the cell-derived glycans through its acetylated
N-terminus, but also changes in the overall conformational ensemble as a result. Only a mini-
mal increase in signal intensity was observed for αSun with PNGase F–cleaved glycans (Fig
6C). By a filtration-based assay, both monomer and PFF αSacetyl were found to pull down
PNGase F–cleaved glycans from solution (S7E Fig). In contrast to GPMV images, there was no
evidence of glycan-mediated assembly of αSacetyl in solution (S7B Fig). This may reflect a dif-
ference in αSacetyl binding to disperse glycans in solution compared to the relatively high den-
sity of glycans on the GPMV surface. Alternatively, it could be due to the absence of the
relevant glycoprotein(s) because αSacetyl binding may involve interactions both with N-linked
glycans as well as the associated glycoprotein(s).
Neurexin 1β drives internalization of αSacetyl
Our results to this point demonstrate that the uptake of both monomer and PFF αSacetyl by
SH-SY5Y cells or primary neurons is strongly impacted by interactions with complex, N-
linked glycans. Our biophysical measurements with GPMVs and isolated carbohydrates sup-
port this observation. This prompted efforts to identify a specific glycoprotein binder partner
for αSacetyl. One recent screen of transmembrane proteins identified neurexin 1β and lympho-
cyte activation gene 3 (LAG3), both of which contain a single N-linked glycosylation site in
their extracellular domains, as binding partners for αSun [9]. Although this study did not
address the impact of N-terminal acetylation of αS, nor of glycosylation of the neurexin 1β or
LAG3, it found that both receptor proteins exhibit specificity for PFF over monomer αSun,
with the effect more striking for LAG3. To specifically address a possible role for glycosylation
of these proteins in αS uptake, HEK cells were transfected with either LAG3 or neurexin 1β,
each bearing an enhanced green fluorescent protein (eGFP) tag on its intracellular domain
(S8A Fig). At comparable transfection levels, the proteins localized to the plasma membrane,
as expected (S8B Fig). αS was labeled with AL594 (αS-AL594) to allow for simultaneous imag-
ing of the transfected protein and exogenously added αS. In the absence of LAG3 or neurexin
1β, no uptake of αSacetyl or αSun monomer or PFF by HEK cells was observed (S4B Fig). Upon
the addition of either αSacetyl or αSun PFFs to LAG3 expressing cells, colocalization with LAG3
on the plasma membrane followed by uptake was observed (Fig 7A). Consistent with the
results of the screen that identified these proteins, neither colocalization nor uptake were
detected for monomer αSun (Fig 7A and 7C), nor did we observe it for monomer αSacetyl (Fig
7A and 7C). Treatment of the LAG3-expressing cells with PNGase F did not decrease uptake
of αSun or αSacetyl PFFs (Fig 7B and 7C).
The results from the neurexin 1β expressing HEK cells stand in striking contrast. Both
monomer and PFF αSacetyl were internalized by these cells where they colocalized in distinct
intracellular puncta (Fig 7D and 7F). Intracellular puncta containing neurexin 1β were not
observed in the absence of αS (S8A Fig), demonstrating that αSacetyl drives internalization of
neurexin 1β during its uptake. We saw no evidence of uptake of monomer or PFF αSun in
neurexin 1β expressing HEK cells (Fig 7D and 7F). At short incubation times, both αSun and
αSacetyl PFFs colocalized with neurexin 1β on the cell surface; however, only αSacetyl PFFs were
internalized upon longer incubation (S8C Fig). Treatment of neurexin 1β transfected HEK
cells with PNGase F greatly decreased binding and uptake of αSacetyl monomer and PFF (Fig
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7E and 7F). Moreover, neurexin 1β maintained its plasma membrane localization (Fig 7E).
These data identify neurexin 1β and its glycosylation as key modulators of pathogenic cell-to-
cell transmission of αSacetyl.
Discussion
In this study, we present compelling evidence that cellular internalization of αSacetyl by primary
neurons and SH-SY5Y cells is dependent upon complex, N-linked glycans. αSacetyl binds to
these complex, N-linked glycans in solution and on cell-derived proteoliposomes. Glycan
binding is a novel result for αSacetyl, and we propose that it is likely to be critical for recognition
of functional protein binding partners. We identify one of those binding partners, neurexin
1β, and show that both its binding to αSacetyl and the consequent uptake of αSacetyl are depen-
dent upon its glycosylation.
Critically, the underlying factor in our discovery is our use of αSacetyl and our ability to
make direct comparisons between αSacetyl and αSun. Mass spectrometry analysis of αS derived
from mammalian brain tissue and various mammalian cells types, as well as from post-mortem
human brain tissue, note the presence of the N-terminal acetyl modification on both soluble
and insoluble forms of the protein [11,14,15,36,37]. However, despite the fact that αSacetyl can
be produced in Escherichia coli [19], many studies—including those aimed at understanding
Fig 6. Binding of αSacetyl to isolated cell-surface N-linked glycans. (A) Diffusion time of αSacetyl-AL488 and αSun-
AL488 (80 nM) as a function of PNGase F–derived glycan concentration measured by FCS. (B) Comparison of αSacetyl-
AL488 and αSun-AL488 binding to carbohydrates (30 μg) cleaved by the indicated endoglycosidases as measured by
FCS. (C) Percent increase in peak intensity for selected residues (n = 9: T22, K32, T44, H50, T59, T64, G86, G93, and
N103) strongly enhanced by glycan binding relative to selected residues (n = 9: A17, A27, L38, V40, V71, V95, I112,
E130, and Y136) weakly affected by glycan binding. Measurements were performed for αSacetyl in the presence of
PNGase F–cleaved glycans, H-Tri, and GlcNAc and for αSun with PNGase F–cleaved glycans. The ratio of sugar to
protein used is indicated. (D) Cross-sections from 15N-1H HSQC spectra along the nitrogen dimension at 8.15 ppm for
αSacetyl in the absence (gray) and in the presence of PNGase F–derived glycans (orange). For (A–C), data are presented
as mean ± SD, n = 3. ���P< 0.0001 by Student t test). The underlying data for this figure can be found in S1 Data. αS,
α-Synuclein; αSacetyl, N-terminally acetylated αS; αSun, unmodified αS; AL488, Alexa Fluor 488; FCS, fluorescence
correlation spectroscopy; GlcNAc, N-acetylglycosamine; H-Tri, H-Trisaccharide; ns, not significant; HSQC,
heteronuclear single quantum coherence; PNGase F, peptide-N-glycosidase F.
https://doi.org/10.1371/journal.pbio.3000318.g006
Glycan-dependent cellular uptake of α-Synuclein
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000318 June 18, 2019 11 / 29
Glycan-dependent cellular uptake of α-Synuclein
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000318 June 18, 2019 12 / 29
function and uptake mechanisms of αS—still rely on the unmodified protein. Current esti-
mates are that approximately 80% of mammalian proteins are modified by N-terminal acetyla-
tion [38]. In contrast to other protein modifications, including side-chain acetylation, no N-
terminal deacetylase enzymes have yet been identified, suggesting that N-terminal acetylation
is not reversible [39]. To illustrate, one recent study found fractional acetylation on lysines 6
and 10 of αS from mouse brain but that the N-terminal acetyl group was ubiquitously present
[11]. For many N-terminally acetylated proteins, e.g., tropomyosin binding to actin [40], this
modification is required for recognition of binding partners [41]. Our current work demon-
strates that this is true for αSacetyl and neurexin 1β (Fig 7) and may also be true for other cellu-
lar binding partners of αS. Moreover, the increased uptake (Figs 2 and 3), as well as the
resulting enhancement of intracellular aggregate formation induced by αSacetyl PFFs relative to
αSun PFFs (Fig 1), provide compelling evidence that N-terminal acetylation of αS has physio-
logical consequences that thus far have been overlooked. From our findings, we speculate that
the increased potency of αSacetyl PFFs in inducing aggregation of endogenous neuronal αS (Fig
1) may result from more rapid internalization of αSacetyl PFFs relative to αSun PFFs. We antici-
pate that our results may help reconcile conflicting cellular and animal models with biochemi-
cal and biophysical studies of αS in which the protein may lack the appropriate modifications.
Disordered proteins such as αSacetyl often participate in highly specific—but relatively low-
affinity—interactions [42]. As such, multivalency provides sufficient avidity for biological inter-
actions between disordered proteins and binding partners in vivo, in examples as diverse as
tubulin polymerization [43], liquid-liquid phase separation [44], and nuclear transport [45].
Intriguingly, interactions between glycan-binding proteins—including lectins—and their bind-
ing partners are often described in the same terms. The binding between these proteins and a
single glycan is often relatively low affinity (μM-mM) [46]. We estimate the apparent Kd for
monomer αSacetyl and PNGase F–derived glycans in solution from the FCS data shown in Fig
6A to be approximately 10–20 μM. Multivalency both enhances the affinity and confers specific-
ity on the interaction, as high affinity binding only occurs when the correct cluster of glycans is
present and in the correct orientation. This requirement may underlie the differences we
observe for αSacetyl in its interactions with SH-SY5Y and primary neurons relative to HEK cells.
While complex N-linked glycans are abundant on all mammalian cells membranes, there are
significant differences in the specific glycome between cell types; moreover, the glycome may be
modified in response to development or disease [47]. Most glycan-binding proteins are mem-
bers of well-characterized families and share similar structures or amino acid sequences [48].
To our knowledge, there are no prior examples of entirely disordered proteins showing selective
binding to complex, N-linked glycans, further underscoring the novelty of our results.
Monomer αS is disordered in solution, with transient helical structure in the amino termi-
nus [33]. N-terminal acetylation enhances the helical propensity of the first 12 residues of αS,
Fig 7. Glycosylated neurexin 1β is a receptor for αSacetyl. (A) HEK cells transfected with LAG3-eGFP after
incubation with monomer or PFF αSacetyl-AL594 or αSun-AL594. (B) HEK cells transfected with LAG3-eGFP but
treated with PNGase F prior to incubation with monomer or PFF αSacetyl-AL594 or PFF αSun-AL594. (C)
Quantification of uptake of monomer and PFF αS-AL594 by LAG3-eGFP transfected HEK cells and +/− PNGase F
treatment quantified by puncta analysis (for αSacetyl and αSun PFFs, as no significant uptake of monomer αSacetyl or
αSun is observed without treatment). (D) As in (A) but HEK cells transfected with neurexin 1β-eGFP. (E) As in (B) but
HEK cells transfected with neurexin 1β-eGFP. (F) As in (C) but HEK cells transfected with neurexin 1β-eGFP and with
analysis of monomer αSacetyl and αSun. All internalization measurements with 200 nM monomer or 200 nM PFF
(monomer units, 20:1 αS:αS-AL594) n = 50 cells, 3 independent experiments, ���P< 0.0001 by Student t test). Scale
bars = 20 μm. The underlying data for this figure can be found in S1 Data. αS, α-Synuclein; αSacetyl, N-terminally
acetylated αS; αSun, unmodified αS; AL594, Alexa Fluor 594; eGFP, enhanced green fluorescent protein; HEK, human
embryonic kidney 293T; LAG3, lymphocyte activation gene 3; PFF, preformed fibril; PNGase F, peptide-N-glycosidase
F.
https://doi.org/10.1371/journal.pbio.3000318.g007
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as well as exerting long-range effects up through approximately residue 50 [49]. These changes
in conformational sampling conferred by N-terminal acetylation may have a role in the selec-
tive glycan binding of αSacetyl relative to αSun. Also relevant to our study, which finds that both
monomer and PFF αSacetyl interact with N-linked glycans, there are several recent structures of
αS fibrils that found that the first approximately 45 residues of αS remain flexible and
extended—and thus presumably available for binding—in aggregates [50–52]. That both
monomer and PFF αSacetyl and αSun are internalized by SH-SY5Y cells, while only αSacetyl
uptake is impacted by N-linked glycans and only PFF αSun uptake is impacted by Heparinase,
strongly suggests that there are multiple modes by which αS interacts with the extracellular
plasma membrane. For αSacetyl, binding to the extracellular membrane is driven by its specific
interactions with N-linked glycans. For αSun, binding appears to be derived primarily from
interactions with outer leaflet lipids and, for PFF αSun, proteoglycans. In all cases, altering the
amount of bound αS, whether by cleaving a specific carbohydrate or increasing the amount of
glycoprotein (as with neurexin 1β), correspondingly alters the amount of internalized αS.
One consequence of our identification of αSacetyl as a glycan-binding protein is that it elicits
a reconsideration of interactions between αS and putative binding partners. Many of the pro-
teins identified as such, including glucocerebrosidase [53] and Rab3b [54], as well as the LAG3
and neurexin 1β [9] examined here, contain N-linked glycosylation sites. Consistent with the
description of glycan-binding proteins above, our results with LAG3 and neurexin 1β empha-
size the relevance of the specific glycans modifying the glycoprotein in determining binding of
αSacetyl. Both LAG3 and neurexin 1β are modified by N-linked glycans; however, only the gly-
cans on neurexin 1β mediate binding and uptake of αSacetyl (Fig 7). As αS is a major target for
drug development to treat Parkinson disease and other synucleinopathies, identification of
αSacetyl as a glycan-binding protein provides new considerations for therapeutic approaches.
Materials and methods
Ethics statement
The primary neurons used in this manuscript were purchased from Neurons R Us Culture Ser-
vice Center at Penn Medicine Translational Neuroscience Center (PTNC) at the University of
Pennsylvania. The use and care of animals were in accordance with the NIH Guide for the
Care and Use of Experimental Animals, and protocols were approved by the University of
Pennsylvania Institutional Animal Care and Use Committee (IACUC).
αS expression and purification
αS was expressed in E. coli BL21 cells; for αSacetyl, BL21 stocks containing the N-terminal acet-
yltransferase B (NatB) plasmid with orthogonal antibiotic resistance were used. The purifica-
tion of both αSacetyl and αSun protein was carried out as previously described [19], with minor
modifications. Briefly, two ammonium sulfate cuts were used (0.116 g/mL and 0.244 g/mL)
with αS precipitating in the second step. The pellet was resolubilized in Buffer A (25 mM Tris
[pH 8.0], 20 mM NaCl, 1 mM EDTA) with 1 mM PMSF and dialyzed against Buffer A to
remove ammonium sulfate. Dialyzed samples were loaded to an anion exchange column (GE
HiTrap Q HP, 5 ml) and eluted with a gradient to 1 M NaCl. αS elutes at approximately 300
mM NaCl. Fractions containing αS were pooled and concentrated using Amicon Ultra con-
centrators (3,000 Da MWCO). Concentrated samples were then loaded to a size exclusion col-
umn (GE HiLoad 16/600 Superdex75) and eluted at 0.5 ml/minute. Fractions containing αS
were again pooled and concentrated, then stored at −80˚C. All αS constructs used in this work
were checked by matrix-assisted laser desorption/ionization (MALDI) to confirm correct
mass and presence of acetylation (S1 Fig).
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For NMR measurements, 15N-labeled αS was grown in E. coli BL21 stocks containing the
NatB plasmid in minimal medium (6 g/L Na2HPO4.7H2O, 3 g/L KH2PO4, 0.5 g/L NaCl, 1 mM
MgS04, 300 μM CaCl2, 0.5 g/L 15NH4Cl) instead of LB medium and purified as described
above.
αS labeling
αS was site-specifically labeled at a single position by introduction of a cysteine at either resi-
due 9 or residue 130. For labeling reactions, freshly purified αS (typically 200–300 μL of
approximately 200 μM protein) was incubated with 1 mM DTT for 30 minutes at room tem-
perature to reduce the cysteine. The protein solution was passed over 2 coupled HiTrap Desalt-
ing Columns (GE Life Sciences, Pittsburgh, PA) to remove DTT and buffer exchanged into 20
mM Tris (pH 7.4), 50 mM NaCl, and 6 M guanidine hydrochloride (GdmCl). The protein was
incubated overnight at 4˚C with stirring with 4× molar excess AL488 or AL594 maleimide
(Invitrogen). The labeled protein was concentrated and buffer exchanged into 20 mM Tris
(pH 7.4), 50 mM NaCl using an Amicon Ultra 3K Concentrator (Millipore, Burlington, MA),
with final removal of unreacted dye and remaining GdmCl by passing again over a set of cou-
pled desalting columns equilibrated with 20 mM Tris (pH 7.4), 50 mM NaCl.
For dual fluorophore labeling for FRET measurements, cysteines were introduced at resi-
dues 9 and 72. The protein was labeled as described above, with the following modifications.
The protein was first incubated with donor fluorophore AL488 maleimide at a ratio of protein:
dye of 1:0.5 for 2 hours at room temperature with stirring. Then, 4× molar excess of acceptor
fluorophore AL594 maleimide was added, and the reaction was continued overnight at 4˚C.
The labeled protein was separated from unreacted dye as described above. αS labeled at these
positions has been extensively studied in our lab; as documented in our previous publications,
they do not perturb αS binding to lipid membranes and serve as excellent reporters of different
conformations of membrane-associated αS [35,55].
Fibril formation
αS PFFs were prepared as previously described [21]. Briefly, 100 μM αS was mixed with 5 μM
αS-AL488 in 20 mM Tris (pH 7.4) and 100 mM NaCl. To induce aggregation, this solution
was incubated at 37˚C for 5 days with agitation (1,500 rpm on an IKA MS3 digital orbital
shaker) in parafilm-sealed 1.5 mL Eppendorf tubes to ensure minimal solvent evaporation.
The aggregation reaction was analyzed by Congo Red absorbance by diluting 10 μl of the
aggregation solution in 140 μl 20 μM Congo Red. The mature fibrils were then pelleted by cen-
trifugation (13,200 rpm for 90 minutes at 4˚C), and the supernatant was removed. Fibers were
resuspended in an equal volume (relative to supernatant) of 20 mM Tris (pH 7.4), 100 mM
NaCl. Mature fibers were subsequently fragmented on ice using a sonicator (Diagenode UCD-
300 bath sonicator) set to high, 30 seconds’ sonication followed by a delay period of 30 seconds
—10 minutes total—to form PFFs.
Assessment of fibrillar material
TEM and PAGE were used to characterize fibrillar αS (S1 Fig). For TEM, 10 μL of aggregated
protein samples (from both before and after sonication) were incubated on TEM grids
(400-mesh Formvar carbon-coated copper, Electron Microscopy Sciences, Hatfield, PA) for 1
to 2 minutes. Sample solution was wicked with filter paper, and the grid was washed with
water to remove any excess material and improve background contrast. Grids were then incu-
bated with 1% (w/v) aqueous uranyl acetate solution (10 μL) for 30 to 60 seconds. Excess ura-
nyl acetate was wicked away with filter paper, and grids were air dried. TEM images were
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collected using a JOEL JEM 1011 TEM (JEOL, Peabody, MA) (operating voltage 100 kV)
equipped with a charge-coupled device camera (ORIUS 832. 10W; Gatan, Pleasanton, CA).
The lengths of the PFFs post sonication were quantified using the Fiji measuring tool on TEM
images [57].
For PAGE, aggregated protein solutions were centrifuged to pellet the aggregated material.
The supernatant was removed and pellet was resuspended in the starting volume of buffer.
Both supernatant and resuspended pellet (20 μL) were loaded on a 4% to 12% polyacrylamide
gel. Gels were imaged using a Typhoon FLA7000 gel imager (GE Life Sciences, Pittsburgh, PA)
using Coomassie stain mode.
Cell culture
SH-SY5Y and HEK cells were grown at 37˚C under a humidified atmosphere of 5% CO2. The
SH-SY5Y cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) plus 10% fetal
bovine serum, 50 U/ml penicillin, and 50 μg/ml streptomycin. The HEK cells were cultured in
DMEM supplemented with 10% FBS, 2 mM L-glutamine, and 100 units/ml penicillin-
streptomycin.
Cells were passaged upon reaching approximately 95% confluence (0.05% Trypsin-EDTA,
Life Technologies, Carlsbad, CA), propagated, and/or used in experiments. Cells used in
experiments were pelleted and resuspended in fresh media lacking Trypsin-EDTA.
Primary neuronal culture
Primary neuronal cultures were obtained from the Neurons-R-Us facility at the University of
Pennsylvania. They were prepared from E15-E17 embryos of CD1 mice. All procedures were
performed according to the NIH Guide for the Care and Use of Experimental Animals and
were approved by the University of Pennsylvania IACUC. Dissociated hippocampal neurons
were plated onto sterile, poly-D-lysine coated on IBIDI chambers at 200,000 cells/coverslip for
live cell imaging and were allowed to mature for 5 days in complete neuronal medium (neuro-
basal without phenol red [Thermo Fisher, Waltham, MA], 5% B27 supplement [Thermo
Fisher]). Medium was partially exchanged every 3 to 4 days.
GPMVs
GPMVs are blebs obtained directly from the cell plasma membrane that contain lipid bilayers
and the embedded membrane proteins but lack the other biological components of the cell
[31]. GPMVs were isolated from SH-SY5Y and HEK cells according to established methods
[56]. Briefly, cells were plated in 25 cm2 culture flasks and cultured for 48 hours, washed with
GPMV buffer (10 mM HEPES, 150 mM NaCl, 2 mM CaCl2 [pH 7.4]) twice, and then exposed
to 25 mM formaldehyde and 2 mM DTT for 2 hours to induce blebbing. To reduce the content
of DTT, GPMVs were dialyzed in GPMV buffer prior to use in experiments. GPMVs were also
created using N-ethylmaleimide as the blebbing reagent, with comparable results. The phos-
pholipid content of final material was measured by total phosphate assay.
Phosphate assay
Lipid concentrations for GPMV preparations were estimated by measuring total phosphate,
assuming that all measured phosphate is from phospholipids and that all lipids are phospholip-
ids. This is a practical assumption designed to ensure reproducibility.
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Enzymatic cleavage of carbohydrates
For cleavage of carbohydrates from GPMVs, endoglycosidases were added to the GPMVs in
GPMV buffer at concentrations recommended by the manufacturers (PNGase F: 5,000 units/
ml; Endo H: 2,500 units; Heparinase I/III: 2,500 units) and incubated at 37˚C for 6 hours.
PNGase F was tagged with a chitin binding domain (Remove-IT PNGase F, New England Bio-
labs, Ipswich, MA). For the images shown in this manuscript, the enzyme was removed by
incubation of GPMVs with 50 μl of chitin binding magnetic beads. Control experiments were
conducted without removal of PNGase F and found to be comparable. Cleavage of N-linked
glycans by PNGase F was confirmed by comparing images of GPMVs +/− PNGase F treatment
after incubation with 50 nM conA, a lectin that binds to binding to α-D-mannose and α-D-
glucose moieties, or wheat germ agglutinin, a lectin that binds to N-acetyl-D-glucosamine and
sialic acid. A significant decrease in the amount of both proteins is observed in these images
(S6B Fig).
For cleavage of carbohydrates from cells, cells were first plated for 42 hours. After 42 hours,
media were removed from cells and replaced with FBS-free media complimented with the
endoglycosidase (PNGase F: 5,000 units/ml; Endo H: 2,500 units; Heparinase I/II: 2,500 units).
The cells were incubated at 37˚C under a humidified atmosphere of 5% CO2 for an additional
6 hours. The media were then removed and replaced with cell growth media prior to the addi-
tion of αS. Cleavage of N-linked glycans from cells was confirmed by comparing images +/−-
PNGase F treatment after incubation with 50 nM conA-AL488, showing a significant reduc-
tion in the amount of conA bound (S5D Fig).
To ensure that PNGase F is removed from GPMVs or cells after incubation (and therefore
does not remain associated with either, blocking potential αS binding sites), we compared the
amount of PNGase F added to either GPMVs or cells with that removed after incubation.
PNGase F (5,000 units/ml) containing a chitin domain was added to chambers containing
either GPMVs or cells and was incubated at 37˚C for 6 hours, as for the experiments described
above. After incubation, the buffer or media containing PNGase F were removed and incu-
bated with chitin magnetic beads to isolate and concentrate the enzyme. Blank chambers con-
taining only PNGase F in buffer or media were subjected to the same treatment; 20 μL of each
sample was run on a 4%–12% polyacrylamide gels and stained with Coomassie blue. Gels were
imaged using a Typhoon FLA7000 gel imager (GE Life Sciences, Pittsburgh, PA) using Coo-
massie stain mode. The gels indicate that essentially all of the enzyme is removed (S9A Fig).
Quantification of carbohydrates
Concentrations of carbohydrates isolated from GPMVs or cells were quantified by using the
Total Carbohydrate Quantification Assay Kit (Abcam, Cambridge, MA) following the manu-
facturer’s instructions. Briefly, the carbohydrates are first hydrolyzed to monomer sugar units
and then converted to furfural or hydrofurfural. These compounds are converted to chromo-
gens, which can be detected by absorbance at 490 nm. Glucose was used to generate a standard
curve for calculation of the total carbohydrate concentration of the samples.
αS-captured carbohydrate pull-down assay
Carbohydrates cleaved and isolated from GPMVs (50 μg) were incubated with 100μM αS in
100μL 10 mM HEPES, 150 mM NaCl, 2 mM CaCl2 (pH 7.4) for 1 hour at room temperature.
Binding reaction mixes were transferred to Amicon Ultra (3,000 Da MWCO) centrifugal con-
centration devices that had been washed with 500μL deionized water. The concentrators were
centrifuged for 5 minutes at 4,200 rpm and the filtrates collected. The flow-through contains
carbohydrates that did not bind αS and thus were not retained in the chamber of the
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concentrator. The amount of carbohydrate in the flow-through was quantified by the total car-
bohydrate assay as described above. The fraction of carbohydrate bound and retained by αS
(Ccaptured) was calculated relative to the starting concentration (50 μg) of the carbohydrate mix-
ture, using
Ccaptured ¼ Ctotal   Cflow  through ð1Þ
where Ctotal corresponds to the absorption of the starting stock concentration of carbohydrates
used and Cflow−through is the absorption of the flow-through.
Samples containing αS with no glycans or conA with 50 μg glycans were used as negative
and positive controls, respectively. As expected, no signal at 490 nm was detected for the αS-
only sample; the conA results are shown in S7E Fig. The absorbance of flow-through at 280
nm was measured, confirming that all protein was retained in the concentrator and could not
be detected in the flow-through.
Cell imaging and analysis
All cell imaging was carried out by confocal fluorescence microscopy using an Olympus
FV3000 scanning system configured on a IX83 inverted microscope platform with a 60× Plan-
Apo/1.1-NA water-immersion objective with DIC capability (Olympus, Tokyo, Japan). For all
experiments, the gain setting for the blue channel was kept constant from sample to sample
(excitation 488 nm, emission BP 500–540 nm). For detection of αS-AL594, the green channel
was used (excitation 561 nm, emission BP 570–620 nm). Images were obtained in 8-well ibidi
chambers (μ-Slide, 8-well glass bottom, ibidi GmbH, Germany) coated with Poly-D-lysine and
were seeded with 20,000–25,000 cells/well. Cells were cultured for 48 hours after passage
before beginning experiments. For cellular uptake experiments, 200 nM αS-AL488 was incu-
bated with cells for 0 to 24 hours before acquiring images. For experiments using deglycosy-
lated cells, cells were pretreated with the tested endoglycosidase for 6 hours as described above
prior to addition of protein. For colocalization with lysosomes, cells were treated with 75 nM
Lysotracker Deep Red (Life Technologies, Carlsbad, CA) for 1 hour prior to imaging. For all
experiments, the gain setting for each channel was kept constant from sample to sample.
Image acquisition and processing were performed with the software accompanying the
FV3000 microscope and Image J software [57]. For SH-SY5Y cells, internalized αS was quanti-
fied either by analysis of the punctate structures in the cells or by the total cellular fluorescence;
for primary neurons, internalized αS was quantified by total cellular fluorescence. For total cel-
lular fluorescence, the integrated fluorescence intensity of the cells is reported. Cellular puncta
were analyzed using the Image J particle analysis plug-in. This algorithm detects puncta
through a user-defined threshold and counts the number of puncta that meet or exceed the
threshold. The threshold was initially defined by manual identification and averaging of a sub-
set of puncta. Colocalization with lysosomes was computed by obtaining a Pearson coefficient
using the ImageJ plugin for colocalization (Coloc_2).
Endocytosis inhibition
For inhibition of exocytosis experiments, monomer αS-AL488 (200 nM) or PFFs (200 nM in
monomer units, 20:1 αS:αS-AL488) was initially incubated with cells for 30 minutes at 4˚C.
Control cells were moved to 37˚C while the endocytosis-inhibited cells were incubated at 4˚C
for another 4 hours before acquiring images. For all experiments, the gain setting for each
channel was kept constant from sample to sample. Image acquisition and processing were
achieved using the software accompanying the FV3000 microscope and Image J software [57].
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GPMV imaging and analysis
All GPMV images were carried using a PicoQuant MicroTime 200 time-resolved fluorescence
system based on an inverted Olympus IX73 microscope (Olympus, Tokyo, Japan) with a 60×
Plan-Apo/1.4-NA water-immersion objective using a 482 nm excitation laser and a frame size
of 512 × 512 pixels. Images acquired with this instrument were in lifetime mode but were inte-
grated to obtain intensity-based images comparable to typical confocal images. This instru-
ment has the advantage of very sensitive avalanche photodiode detectors (SPADs) that are
capable at detecting nM concentrations of protein. Fluorescence intensities were analyzed via
the lifetime mode (both intensity and FRET images) using SymPhoTime 64 (PicoQuant, Ber-
lin, Germany). The intensity of images was then adjusted on ImageJ analysis program [57].
For FLIM-FRET experiments, measurements were made of donor-only and donor-accep-
tor labeled proteins. SPAD signals were processed with the TimeHarp 300 photon counting
board and analyzed with the SymPhoTime 64 software (PicoQuant, Berlin, Germany) taking
into account the instrument response function to allow consideration of short lifetime compo-
nents with a high accuracy. FLIM images were acquired for 180 seconds, with a pixel integra-
tion time of 40 μs per pixel and an average photon count rate of 10,000–30,000 counts per
second. Regions of interest of the GPMV membrane were selected from FLIM images, and
fluorescent lifetimes were obtained from TCSPC decay curves fitted by an exponential equa-
tion using the SymPhoTime 64 software. Fitting of the fluorescence images was then per-
formed pixel wise with a single exponential model on all pixels above an intensity threshold of
200 photons. By characterizing donor lifetime in the absence and presence of acceptor, ETeff
can be calculated from:




where τDA and τD and are the donor excited state lifetime in the presence and absence of
acceptor. Six FLIM images were recorded for each of 3 biological repeats per condition. The
histograms shown in Fig 5 represent ETeff values for selected pixels from equatorial sections of
the GPMVs as indicated in the images to their left. The histograms were fit with a Gaussian
function to extract the mean ETeff.
Images were obtained in 8-well NUNC chambers (Thermo Scientific, Rochester, NY) con-
taining 250 μl of GMPV at 5 μM phospholipid concentration and 80 nM of αS-AL488. For all
experiments using these chambers, the chambers were passivated by polylysine-conjugated
PEG treatment to prevent any nonspecific absorption to the chamber surfaces [55]. Quantifi-
cation of fluorescence on GPMVs resulting from bound αS-AL488 was calculated by deter-
mining the integrated intensity per pixel. The fluorescence intensities of 10 GPMVs per
condition were quantified.
FCS
FCS measurements were carried out on a lab-built instrument, as described previously [35]. A
488-nm–wavelength laser was adjusted to 5 μW prior to entering the microscope. Fluores-
cence emission was collected through the objective and separated from laser excitation using a
Z488RDC Long-Pass Dichroic and an HQ600/200M Band-Pass Filter (Chroma, Bellows Falls,
VT). The fluorescence emission was focused into the aperture of a 50-μm–diameter optical
aperture fiber (OzOptics, Canada) directly coupled to an avalanche photodiode. A digital cor-
relator (Flex03LQ-12; Correlator.com) was used to generate the autocorrelation curves. For
each experiment, 30 autocorrelation curves of 10 seconds each were acquired and averaged
together to obtain statistical variations. These average autocorrelation curves were then fit to a
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function for single fluorescent species undergoing Brownian motion in a three-dimensional
Gaussian volume weighted by the inverse square of the SD:















where G(τ) is the autocorrelation function for translational diffusion as a function of time τ, N
is the average number of fluorescent molecules in the laser focal volume, and τD is the transla-
tional diffusion time of the particles. The structure factor, s, is the ratio of the radial to axial
dimensions of the focal volume and was obtained from a calibration procedure using AL488
hydrazide dye solutions (s = 0.2) and fixed for all subsequent fitting. Several datasets of auto-
correlation curves obtained in the presence of carbohydrates were analyzed considering a sin-
gle component system. For carbohydrate binding, both the diffusion time, τD (Fig 6A and 6B,
S4C, S7A, S7C, S7D and S9B Figs), and the number of molecules, N (Fig 4C and 4E, S7B Fig),
were analyzed.
GPMV binding and cellular uptake by FCS
FCS was used to monitor αS both binding to GPMVs and uptake by cells. FCS measurements
were made on the instrument described above. For GPMV binding, experiments were per-
formed in 8-well NUNC chambers (Thermo Scientific, Rochester, NY) containing 250 μl of
GMPV at 5 μM phospholipid concentration. The laser focal volume was located to a height of
100 μm from the bottom surface of the wells, above all GMPVs. αS-AL488 (80 nM) was added
to wells with GPMVs, and the autocorrelation measurements were taken immediately and
after 60 minutes. Each curve was integrated for 30 seconds and repeated 10 times, and data
were analyzed as described above. Binding was quantified by measuring the change in the
number of molecules, N, of fluorescently labeled αS present in the solution surrounding the
GMPVs relative to the starting concentration. There was no change in the diffusion time of the
αS that remained in the cell media over this time course, evidence that protein is stable and the
fluorophore intact (S9B Fig).
For cell uptake experiments, cells were plated in phenol red-free medium in 8-well ibidi
chambers (μ-Slide, 8-well glass bottom, ibidi GmbH, Germany) coated with Poly-D-lysine
wells and cultured for 48 hours prior to measurements. Control wells contained the same vol-
ume of media without cells; these control for nonspecific adsorption of protein to the well sur-
faces. αS-AL488 (200 nM) was added to the wells at the start of the experiment, and the
autocorrelation curves were taken in the medium well above the cells, at a height of 100 μm
from the bottom surface of the wells. The curves were collected at regular intervals, over a
period ranging from 2 to 24 hours, and each autocorrelation curve integrated for 30 seconds,
repeated 10 times. Data were analyzed as described above. Cellular uptake was assessed by
measuring the change in the number of molecules of fluorescently labeled αS present in the
media surrounding the cells relative to the starting concentration. In between measurements,
the chambers were returned to the incubators to maintain the temperature in the wells at
37˚C. As a negative control for both the GPMV binding and cell uptake studies, GPMVs or
cells were incubated with 80 nM eGFP. There was no evidence of eGFP binding to the GPMVs
nor of internalization by SH-SY5Y cells (S9C Fig).
Cellular uptake by PAGE
As an orthogonal approach to the FCS and imaging approached described above, uptake of
both monomer and PFF αS were quantified by PAGE. SH-SY5Y cells were incubated with 200
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nM αS, as described above for FCS uptake experiments. After incubation for the desired time
(1, 3, 5, 8, 12, or 24 hours), the media were removed from cells and stored at 4˚C. After all sam-
ples were collected, 20 μl of each sample was run on a 4%–12% polyacrylamide gel.
To quantify the amount of protein internalized, an identical set of experiments was carried
out, with modifications as described following. For each time point, transferrin-AL488 (100
nM) was added 30 minutes prior to the due time of the time point to serve as a loading control.
At the desired time points, the cells were detached from the wells by 0.05% Trypsin-EDTA
(Life Technologies Carlsbad, CA), pelleted, and lysed in 250 μl RIPA lysis buffer (Thermo
Fisher, Waltham, MA). Cell lysates (20 μl of stock) were run on PAGE gels. Cell lysates (20 μl)
were run on 4%–12% polyacrylamide gels.
Gels of both extracellular and internalized αS were imaged using a Typhoon FLA7000 gel
imager (GE Life Sciences, Pittsburgh, PA) using fluorescent imaging mode to detect αS-AL488
or transferrin-AL488. Image J was used to quantify the bands [57].
Statistical analysis
Data are expressed as the mean±SD and were examined by a one-way analysis of variance
(n = 3). More than 3 experiments were performed, and similar results were obtained. P< 0.05
was considered to be significant.
Trypan blue quenching
Trypan blue solution 0.4% (Thermo Fisher, Waltham, MA) and fresh neurobasal without phe-
nol red, B27, or antibiotic supplementation were equilibrated at 37˚C. A 10× dilution of trypan
blue was prepared freshly in the warmed neurobasal media. The trypan blue solution was then
added to cells dropwise and incubated at 37˚C for an hour prior to imaging. Trypan Blue
quenching was performed for all imaging experiments performed using PFFs and when mono-
mer protein was introduced in experiments utilizing primary neurons. Trypan Blue quenching
was used to eliminate signal from extracellular material, allowing the fluorescence quantifica-
tion of intracellular fluorescence signal.
Propagation of amyloid in primary neurons
Primary wild-type mouse hippocampal neurons (obtained as described above) were grown for
6 days on round coverslips prior to addition of αSacetyl or αSun PFFs (100 nM final PFF concen-
tration). Cells were fixed with 4% (wt/vol) paraformaldehyde and costained with antibodies
specific to αS phosphorylated at serine 129 (rabbit monoclonal phospho 129, 1:250 dilution)
and neuronal tubulin (mouse monoclonal anti-β-III tubulin, 1:100 dilution) after 3-, 7-, and
10-day incubations with PFFs. Primary antibodies were visualized by secondary staining with
AL488 donkey anti-rabbit IgG (Invitrogen, Carlsbad, CA) and AL647 goat anti-mouse IgG
(Invitrogen, Carlsbad, CA) (1:1,000 dilution).
Transfection of HEK cells
HEK cells were transfected with plasmid encoding LAG3-eGFP or Neurexin 1 β-eGFP by
Lipofectamine 3000, following the manufacturer’s directions. The media were removed from
cells 48 hours after transfection and replaced with FBS-free media complimented with PNGa-
seF (5,000 units/ml) for experiments that required PNGaseF treatment. The cells were then
incubated at 37˚C under a humidified atmosphere of 5% CO2 for an additional 6 hours. The
media were then removed and replaced with cell growth media prior to the addition of αS.
Cells were incubated with monomer αS-AL594 (final concentration 200 nM) or PFF αS (final
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concentration 200 nM monomer units, 1:20 labeled:unlabeled) for either 1 hour or 12 hours
prior to imaging.
Flow cytometry
To quantify LAG3-eGFP and Neurexin 1 β-eGFP expression levels, HEK cells were plated and
transfected as above. After 48 hours, cells were detached using 0.05% Trypsin-EDTA, centri-
fuged, and washed with PBS + 2mM EDTA and 2% BSA. The cells were then treated with the
Zombie Yellow fixable cell viability kit (BioLegend San Diego, CA) at room temperature in
PBS + 2 mM EDTA for 20 minutes and then fixed at 4˚C using Cytofix for 20 minutes. Cells
were then placed in PBS + 2 mM EDTA and 2% BSA. Data were collected on an LSR II flow
cytometer (BD Biosciences) and postcollection data were analyzed using FlowJo (Treestar,
flowjo.com) (S8B Fig). Gating was performed on live single cells in the lipofectamine-only
control.
Cell viability
Cell viability was measured colorimetrically using the Cell-Titer Blue (CTB, Promega,
Madison, WI) fluorescence-based assay. Cells were plated at a density 5,000 cells/well in
96-well plates (BD Biosciences, San Diego, CA). Protein was directly introduced to each well
after 48 hours of culture and then incubated for an additional 48 hours. After incubation, 30μL
CTB reagent was added to each well and incubated at 37˚C and 5% CO2 for 2.5 to 5 hours.
Fluorescence of the resorufin product was measured on a FluoDia T70 fluorescence plate
reader (Photon Technology International, Birmingham, NJ). Wells that included vehicle but
not protein served as the negative control (0% toxic), and wells containing 10% DMSO were
the positive control (100% toxic). Percent toxicity was calculated using the following equation:





Each independent variable is the average of 8 plate replicates from the negative control
(<N>), positive control (<P>), and samples (<S>). Results presented for viability experi-
ments are an average of 3 such experiments conducted independently on different days. Error
bars represent the standard error of the mean.
NMR
1H-15N HSQC NMR titrations were carried out at 25˚C using Varian 600 MHz or Agilent 800
MHz spectrometers equipped with room temperature probes. A uniformly labeled 15N-αS
solution was added to either N-linked glycans obtained by PNGase F cleavage from SH-SY5Y
cells or commercially available mono- or trisaccharides at the concentrations indicated in Fig
6C in GPMV buffer (10 mM HEPES, 150 mM NaCl, 2 mM CaCl2 [pH 7.4], 10% D2O; final
concentration of 15N-αS was 350 μM). HSQC spectra were collected with VnmrJ software
(openvnmrj.org) using built-in pulse sequence including WATERGATE solvent suppression
and were analyzed with Mnova software suite (Mestrelab; mestrelab.com/software/mnova/).
Standard parameters for zero-filling, apodization, and baseline correction were applied. 1H
chemical shifts were referenced using water resonance, and 15N chemical shifts were refer-
enced indirectly based on gyromagnetic ratios of respective nuclei. Previously assigned αS
backbone resonances were used [49].
The PNGase F–derived glycans are a heterogeneous mixture of complex glycans of various
sizes and monosaccharide building blocks. For comparison with the mono- and trisaccharide
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measurements, we approximated the amount of PNGase F–derived carbohydrate from μg (as
determined by the carbohydrate quantification assay described above) to μM using the molec-
ular weight of glucose, 180.16 g/mol. Thus, the 1.3:1 molar ratio reported in the NMR refers to
the approximate number of available monosaccharide groups from the PNGase F glycans; the
actual concentration of complex N-linked glycans is much lower.
Binding to the PNGase F–derived glycans results in nonuniform peak intensity increases
throughout the sequence of αS. For analysis, 9 peaks showing large increases (T22, K32, T44,
H50, T59, T64, G86, G93, and N103) and 9 peaks showing small or no increases (A17, A27,
L38, V40, V71, V95, I112, E130, and Y136) were selected to roughly cover the entire sequence.
The same residues were used for each analyzed dataset. For each set of peaks, the relative mag-
nitude of increase (compared to αS in solution without glycans) expressed as a percentage was
calculated and averaged.
Supporting information
S1 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
and statistical analysis for Figure panels 1B, 2C, 2D, 2E, 3A, 3B, 4C, 4E, 5A, 5B, 6A, 6B,
6C, 6D, 7C, 7F, S1A, S1C, S2B, S3, S4, S5B, S5E, S6D, S7A, S7B, S7C, S7D, S7E, S8B and
S9B Figs.
(XLSX)
S1 FCSfile. FCSFACS file for lipofectamine flow cytometry data in S8B Fig. FCSFACS, flow
cytometry standard.
(FCS)
S2 FCSfile. FCSFACS file for LAG3 flow cytometry data in S8B Fig. FCSFACS, flow cytometry
standard; LAG3, lymphocyte activation gene 3
(FCS)
S3 FCSfile. FCSFACS file for neurexin 1β flow cytometry data in S8B Fig. FCSFACS, flow
cytometry standard.
(FCS)
S1 Fig. Characterization of monomer and PFF αS. (A) MALDI-TOF mass spectrometry was
used to confirm the presence of the N-terminal acetyl group as well as the purity of the samples
for both unlabeled and AL488-labeled αS. The expected masses for αSacetyl
E130C and αSacety-
l
E130C-AL488 are 14,576 and 15,174, respectively; for αSun
E130C and αSun
E130C-AL488, they are
14,434 and 15,132, respectively; the reported values are within expected accuracy for MALDI-
TOF. (B) The fibril morphology before and after sonication was examined by TEM at 100,000x
magnification. Scale bar = 200 μm.(C) Frequency distribution of PFF length following sonica-
tion; 50 fibers were measured, with an average length of 192.2 ± 56.9 nm for αSacetyl and
209.7 ± 110.2 nm for αSun. (D) PAGE analysis at the end of the aggregation assay indicates
that very little monomer αS is present in PFF preparations. 1 = molecular weight standards; 2
= αSacetyl pellet; 3 = αSacetyl supernatant; 4 = αSun pellet; 5 = αSun supernatant. The underlying
data for this figure can be found in S1 Data.
(TIF)
S2 Fig. Time-dependent endocytosis of αSacetyl monomer and PFFs. (A) Time-dependent
uptake of αSacetyl (green) monomer or PFFs by untreated or PNGase F–treated SH-SY5Y cells.
Incubation time indicated above each image. Cells were stained with LysoTracker Deep Red
(purple) prior to imaging. (B) Image overlap statistics for (A) of LysoTracker and αSacetyl
monomer and PFFs at the indicated incubation time. Colocalization was analyzed with the
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Pearson correlation coefficient. A larger coefficient reflects more overlap between αSacetyl-
AL488 puncta and LysoTracker puncta (endosomes). Correlation coefficient was computed
using the ImageJ plugin for colocalization (n = 100 cells, 3 independent experiments). Scale
bars = 20 μm. The underlying data for this figure can be found in S1 Data.
(TIF)
S3 Fig. Quantification of cell uptake measured by PAGE analysis. Uptake of αSacetyl mono-
mer (200 nM αSacetyl-AL488) or PFFs (200 nM in monomer units, 20:1 αSacetyl:αSacetyl-AL488)
by SH-SY5Y cells as measured by PAGE analysis with fluorescence imaging of the gels (to
detect only αSacetyl-AL488). (Upper) Gels show αSacetyl remaining in the media at the time
points indicated above the gels. Uptake is measured by quantifying the decrease of αSacetyl-
AL488 in the media as a function of time. Quantification of the gels is shown as the scatter plot
for monomer and PFF αSacetyl +/− PNGase F treatment. The measurements are analogous to
the FCS measurements shown in Fig 2C in the main manuscript, and the results of both
approaches are comparable. (Lower) Gels show αSacetyl internalized by cells at the time points
indicated above the gels. Uptake is measured by quantifying the amount of αSacetyl-AL488
from lysed cells as a function of time. Transferrin-AL488, which exhibits very rapid uptake
kinetics (S4C Fig), was added to cells for 30 minutes prior to lysis, to be used as loading con-
trol. The scatter plot compares the amount of internalized monomer and PFF αSacetyl, and the
bar plot compares the amount of both forms internalized +/− PNGase F treatment. Quantifica-
tion of gel band intensity was computed using ImageJ. These measurements are analogous to
the image analysis shown in Fig 2C, and the results from both approaches are comparable. For
each experiment, 3 independent measurements were made. The underlying data for this figure
can be found in S1 Data.
(TIF)
S4 Fig. Clathrin-dependent endocytosis. (A) Inhibition of endocytosis monitored by uptake
of αSacetyl monomer or PFFs at 4˚C. Images are shown of uptake of protein at 37˚C and 4˚C
for each condition. Protein was added to the cells followed by incubation at 4˚C for 30 min-
utes. The controls were then moved to 37˚C incubator. The two groups of cells were incubated
in the respective temperatures for an additional 4 hours. (B) HEK cells incubated with αS acetyl
monomer or PFFs for 12 hours. (C) Rates of clathrin-dependent endocytosis of SH-SH5Y and
HEK cells compared by loss of 100 nM transferrin-AL488 from extracellular medium of cells
as measured by FCS. All αSacetyl uptake measurements used 200 nM αS-AL488 monomer or
PFF (concentration in monomer units, 20:1 αS:αS-AL488) Scale bar = 20μm. The underlying
data for this figure can be found in S1 Data.
(TIF)
S5 Fig. Treatment of cells with endoglycosidases. (A) Heparinase treatment of SH-SY5Y
cells inhibits uptake of αSun PFF (upper) but not of αSacetyl PFF (lower). Images made after 12
hours of incubation of SH-SY5Y cells with 200 nM PFF αSacetyl-AL488 or αSun-AL488 (con-
centration in monomer units, 20:1 αS:αS-AL488) following treatment with Heparinase. (B)
Heparinase and Endo H treatments of SH-SY5Y cells do not inhibit uptake of monomer αSace-
tyl. Images were made after 12 hours of incubation of SH-SY5Y cells with monomer αSacetyl-
AL488 (200 nM) following treatment with Endo H or Heparinase. Quantification of monomer
αSacetyl uptake by SH-SY5Y cells treated with Endo H or Heparinase shown relative to PNGase
F–treated or–untreated cells (Fig 2E). Numbers of puncta were computed using the ImageJ
plugin for particle analysis (n = 100 cells, 3 independent experiments, significance analyzed by
Student t test. (C) 50 nM conA-AL488 incubated with SH-SY5Y cells +/− PNGase F treatment.
A significant reduction in the amount of conA-AL488 is observed in cells treated with PNGase
Glycan-dependent cellular uptake of α-Synuclein
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000318 June 18, 2019 24 / 29
F. (D) (Upper) Uptake of transferrin and αSacetyl by PNGase F–treated SH-SY5Y cells. Inter-
nalization of transferrin-AL488 is not impacted by this treatment, indicating that clathrin-
mediated endocytic pathways are functional. Uptake of αSacetyl-AL594 is significantly reduced.
(Lower) As with the SH-SY5Y cells, uptake of transferrin by primary neurons from embryonic
mouse hippocampus is not impacted by PNGase F treatment, indicating that clathrin-medi-
ated endocytic pathways are functional. (E) Colorimetric measure of toxicity following the
incubation of SH-SY5Y cells with 200 nM αSacetyl monomer or PFFs (concentration in mono-
mer units) for times indicated on plots. Data are expressed relative to vehicle-only addition.
Each histogram bar is the average of 8 on-plate repeats across each of 3 independently per-
formed replicates (n = 24). The underlying data for this figure can be found in S1 Data.
(TIF)
S6 Fig. αS binding to and clustering of SH-SY5Y GPMVs is dependent on N-linked gly-
cans. (A) Representative images of SH-SY5Y GPMVs incubated with 100 nM αSacetyl-AL488
and 80 μM of unlabeled αSacetyl. (B) Representative images of SH-SY5Y GPMVs incubated
with 100 nM of αSacetyl-AL488 PFFs (monomer units, 20:1 αS:αS-AL488). (C) As in (B) but
with with αSun-AL488 PFFs. (D) Intensity per pixel of 100 nM αSacetyl-AL488 and αSun-AL488
and 80 μM of unlabeled protein bound to GPMVs with and without PNGase F treatment. (E)
Representative images of PNGase F–treated SH-SY5Y GPMVs incubated with 100 nM
αS-AL488 and 80 μM of unlabeled αS. (F) Representative images of Endo H- and Heparinase-
treated SH-SY5Y GPMVs incubated with 100 nM αSacetyl-AL488 and 80 μM of unlabeled
αSacetyl. (G) Representative images of HEK GPMVs incubated with 100 nM αSacetyl-AL488 and
varying concentrations of unlabeled αSacetyl (indicated). (H) GPMVs incubated with 50 nM
conA-AL488 or 50 nM wheat germ agglutinin-AL488, +/− PGNase F treatment (upper/lower).
(I) GPMVs incubated with 100 nM αSacetyl-AL594 and 80 μM of unlabeled αSacetyl prior to
addition of 50 nM conA-AL488. (J) GPMVs incubated with 80 μM of unlabeled αSacetyl prior
to the addition of 50 nM conA-AL488. For all experiments, GPMVs equivalent to 5 μM total
lipid as measured by the phosphate assay were used. Scale bars = 10 μm. The underlying data
for this figure can be found in S1 Data.
(TIF)
S7 Fig. αS binding to isolated glycans. (A) Averaged autocorrelation curves (30 curves of 10
seconds each) and fits to Eq 3 for αSacetyl in the presence and absence of PNGase F–cleaved gly-
cans. (B) The number of αSacetyl molecules, N, upon, titration with PNGase F–cleaved glycans
by FCS (same measurements as analyzed for diffusion time in Fig 6A). A decrease in N as a
function of glycan concentration would reflect aggregation or oligomerization of the protein;
this is not seen here. (C) Diffusion time of 80 nM conA-AL488 as a function of increasing con-
centrations of PNGase F–derived glycans. (D) Diffusion time of 80 nM αSacetyl-AL488 as a
function of increasing concentrations of Endo H- and Heparinase-derived glycans. Data for
PNGase F–derived glycans also shown for comparison (Fig 6A). (E) Quantification of PNGase
F–cleaved glycans bound to monomer and PFF forms of αSacetyl using total carbohydrate assay
(reported as absorption at 490 nm). For comparison, positive-control conA is shown. All
results are relative to the initial glycan pool, which is treated to the same filtration and quantifi-
cation protocol as the samples. Details of the assay are described in the Materials and methods.
The underlying data for this figure can be found in S1 Data.
(TIF)
S8 Fig. Internalization of αS by HEK cells transfected with LAG3 or neurexin 1β. (A) HEK
cells transfected with eGFP-tagged LAG3 (upper) or eGFP-tagged neurexin 1β (lower), imaged
48 hours after transfection. (B) Transfection efficiencies of eGFP-tagged neurexin 1β (upper:
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approximately 21%) or eGFP-tagged LAG3 (lower: approximately 16%) measured by flow
cytometry. Lipofectamine-only sample was used as an eGFP negative control used for gating
purposes in the analysis. (C) HEK cells transfected with eGFP-tagged neurexin 1β as in (A) but
with the addition of αSacetyl-AL594 or αSun-AL594 PFFs. Cells were incubated with 200 nM
PFFs (concentration in monomer units, 1:20 labeled:unlabeled) for 1 hour prior to imaging.
To visualize the binding of PFFs to the extracellular membrane, no Trypan blue solution was
used in these experiments. Scale bars = 20 μm. The underlying data for this figure can be
found in S1 Data and S1 FCSfile, S2 FCSfile, and S3 FCSfile.
(TIF)
S9 Fig. PNGase F does not remain bound to cell membranes after incubation. (A) The
amount of PNGase F before and after treatment of GPMVs and SH-SY5Y cells was examined
by PAGE. The majority of the enzyme is recovered from the GPMV buffer or cell media, indi-
cating that it does not remain bound to the membranes, potentially blocking αSacetyl binding.
(B) αSacetyl is stable during incubation with cell media during uptake studies. FCS was used to
monitor the diffusion time of αSacetyl in media as a function of time during incubation with
SH-SY5Y cells. The diffusion time is stable over the 24-hour period, indicating that the protein
is not degraded nor is the fluorophore cleaved, both of which would be expected to result in a
faster diffusion time. (C) SH-SY5Y GPMVs and cells do not bind or uptake eGFP, respectively.
eGFP was used as negative control. The addition of 80 nM eGFP to GPMVs shows no evidence
of binding. Likewise, there is no evidence of uptake of eGFP by SH-SY5Y cells following 12
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